EP2004689A4
Antibody purification
Abstract
This record has no abstract on file.
Term
Projected expiry 4 April 2027.
- Priority
- Filed
- Published
- Today
- Projected expiry
12 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11 Sheet 12
Every citation, both ways
| Document | Relation | Office | Category | Cited during | Relevant claims |
|---|---|---|---|---|---|
| WO03102132A2 | Cites | World Intellectual Property Organization (WIPO) | – | Examiner | – |
| WO9633208A1 | Cites | World Intellectual Property Organization (WIPO) | A | Search report | 1-55 |
| WO9957134A1 | Cites | World Intellectual Property Organization (WIPO) | XI | Search report | 1,2,5,6,8,10,11,48-51 |
| EMERY PAUL: "Adalimumab therapy: clinical findings and implications for integration into clinical guidelines for rheumatoid arthritis.", DRUGS OF TODAY (BARCELONA, SPAIN : 1998) MAR 2005 LNKD- PUBMED:15883612, vol. 41, no. 3, March 2005 (2005-03-01), pages 155 - 163, XP002577441, ISSN: 1699-3993 | Non-patent | – | – | Search report | – |
92 members in 16 offices
Priority claims5
| Document | Office | Kind | Date |
|---|---|---|---|
| 789725P | United States of America | – | |
| 78972506 | United States of America | P | |
| 790414P | United States of America | – | |
| 79041406 | United States of America | P | |
| 2007008359 | United States of America | W |
Members92
| Document | Office | Kind | |
|---|---|---|---|
| AU2007235484A1 | Australia | A1 | |
| CA2647029A1 | Canada | A1 | |
| CA2911000A1 | Canada | A1 | |
| WO2007117490A2 | World Intellectual Property Organization (WIPO) | A2 | |
| US2007292442A1 | United States of America | A1 | |
| TW200808821A | Taiwan Province of China | A | |
| MX2008012896A | Mexico | A | |
| WO2007117490A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP2004689A2 | European Patent Office (EPO) | A2 | |
| KR20090005315A | Republic of Korea | A | |
| CN101454025A | China | A | |
| JP2009532474A | Japan | A | |
| RU2008143356A | Russian Federation | A | |
| EP2004689A4This record | European Patent Office (EPO) | A4 | |
| US7863426B2 | United States of America | B2 | |
| US2011002935A1 | United States of America | A1 | |
| SG170837A1 | Singapore | A1 | |
| BRPI0709726A2 | Brazil | A2 | |
| IL194236A0 | Israel | A0 | |
| IL194236D0 | Israel | D0 | |
| ZA200808372B | South Africa | B | |
| CN102391358A | China | A | |
| US8231876B2 | United States of America | B2 | |
| NZ571479A | New Zealand | A | |
| RU2466740C2 | Russian Federation | C2 | |
| CN102887955A | China | A | |
| US2013028903A1 | United States of America | A1 | |
| TWI392684B | Taiwan Province of China | B | |
| AU2013202811A1 | Australia | A1 | |
| AU2013202830A1 | Australia | A1 | |
| AU2013202851A1 | Australia | A1 | |
| JP2013079244A | Japan | A | |
| NZ596517A | New Zealand | A | |
| TW201333030A | Taiwan Province of China | A | |
| US2013273059A1 | United States of America | A1 | |
| US2013280267A1 | United States of America | A1 | |
| AU2007235484B2 | Australia | B2 | |
| US2013309242A1 | United States of America | A1 | |
| US2013323261A1 | United States of America | A1 | |
| CN101454025B | China | B | |
| CN103509116A | China | A | |
| RU2012134840A | Russian Federation | A | |
| JP2014077000A | Japan | A | |
| EP2738178A1 | European Patent Office (EPO) | A1 | |
| EP2738179A1 | European Patent Office (EPO) | A1 | |
| KR20140071452A | Republic of Korea | A | |
| ZA201100565B | South Africa | B | |
| NZ610566A | New Zealand | A | |
| US8883156B2 | United States of America | B2 | |
| US8895009B2 | United States of America | B2 | |
| US8906372B2 | United States of America | B2 | |
| US8916153B2 | United States of America | B2 | |
| NZ611859A | New Zealand | A | |
| SG10201406358SA | Singapore | A | |
| KR20150006085A | Republic of Korea | A | |
| US2015079102A1 | United States of America | A1 | |
| US2015079103A1 | United States of America | A1 | |
| IL194236A | Israel | A | |
| KR20150064254A | Republic of Korea | A | |
| US9096666B2 | United States of America | B2 | |
| US9102723B2 | United States of America | B2 | |
| US2015307605A1 | United States of America | A1 | |
| JP5813618B2 | Japan | B2 | |
| AU2013202811B2 | Australia | B2 | |
| AU2013202830B2 | Australia | B2 | |
| US2015361168A1 | United States of America | A1 | |
| US2015361169A1 | United States of America | A1 | |
| AU2013202851B2 | Australia | B2 | |
| AU2013202851A8 | Australia | A8 | |
| JP2016006069A | Japan | A | |
| US9273132B2 | United States of America | B2 | |
| JP2016029060A | Japan | A | |
| AU2016201494A1 | Australia | A1 | |
| US9328165B2 | United States of America | B2 | |
| JP5947427B2 | Japan | B2 | |
| CN102391358B | China | B | |
| JP5994004B2 | Japan | B2 | |
| JP5997128B2 | Japan | B2 | |
| EP3088410A2 | European Patent Office (EPO) | A2 | |
| EP3088410A3 | European Patent Office (EPO) | A3 | |
| JP2017052753A | Japan | A | |
| US2017136122A1 | United States of America | A1 | |
| AU2016201494B2 | Australia | B2 | |
| US2018036407A1 | United States of America | A1 | |
| US9913902B2 | United States of America | B2 | |
| AU2018201769A1 | Australia | A1 | |
| JP6367277B2 | Japan | B2 | |
| JP2018172416A | Japan | A | |
| US2019298829A1 | United States of America | A1 | |
| US11083792B2 | United States of America | B2 | |
| US2021260186A1 | United States of America | A1 | |
| US2022339284A1 | United States of America | A1 |
25 legal events, as 3 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Applications withdrawn, deemed to be withdrawn, or refused after publication in hong kongWithdrawnWD | WD | HK | |
| Application refused18R | 18R | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION HAS BEEN REFUSEDSTAA | STAA | EP | |
| Refusal decision now finalR003 | R003 | DE | |
| Information related to observations by third parties modifiedORIGINAL CODE: EPIDOSCTIPATPAA | TPAA | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Observations by third partiesORIGINAL CODE: EPIDOSNTIPATPAC | TPAC | EP | |
| Requested extension states of the european patent have changedRAX | RAX | EP | |
| Requested extension states of the european patent have changedRAX | RAX | EP | |
| Requested extension states of the european patent have changedRAX | RAX | EP | |
| Requested extension states of the european patent have changedRAX | RAX | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Supplementary search report drawn up and despatchedA4 | A4 | EP | |
| Requests to designate patent in hong kongDE | DE | HK | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Deferred search report published (corrected)R17D | R17D | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Request for extension of the european patentAX | AX | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 2004689
- Application
- 77548188
Titles3
- German
- ANTIKÖRPERREINIGUNG
- English
- ANTIBODY PURIFICATION
- French
- PURIFICATION D'ANTICORPS
Classification
- CPC, 43
- A61K31/519
- C07K1/14
- A61K39/39591
- C07K1/18
- C07K1/36
- C07K16/065
- C07K16/241
- A61P1/00
- A61P1/04
- A61P11/00
- A61P13/12
- A61P17/00
- A61P17/06
- A61P19/02
- A61P19/06
- A61P25/00
- A61P27/02
- A61P29/00
- A61P29/02
- A61P3/00
- A61P3/04
- A61P31/00
- A61P31/14
- A61P35/00
- A61P37/00
- A61P37/06
- A61P37/08
- A61P43/00
- A61P9/00
- A61P9/10
- A61P3/10
- C07K1/00
- C07K16/00
- C07K1/20
- A61K39/3955
- A61K2039/505
- C07K2317/21
- C07K2317/14
- A61K47/22
- A61K47/26
- C07K2317/94
- A61K2039/54
- A61K2039/545
- IPC, 6
- A61K39 395
- C07K1 18
- C07K1 20
- C07K1 36
- C07K16 00
- C07K16 24
Designated states36
- Contracting states, 32
- Austria
- Belgium
- Bulgaria
- Switzerland
- Cyprus
- Czechia
- Germany
- Denmark
- Estonia
- Spain
- Finland
- France
- United Kingdom
- Greece
- Hungary
- Ireland
- Iceland
- Italy
- Liechtenstein
- Lithuania
- Luxembourg
- Latvia
- Monaco
- Malta
and 8 moreShow fewer
- Netherlands (Kingdom of the)
- Poland
- Portugal
- Romania
- Sweden
- Slovenia
- Slovakia
- Türkiye
- Extension states, 4
- Bosnia and Herzegovina
- Croatia
- North Macedonia
- Serbia